Monday, 26 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Drug
Anhui Anke Biotechnology Receives NMPA Approval for AK2017 Clinical Study
January 26, 2025
Company
Drug
AstraZeneca’s Nexium Approved by NMPA for Adolescent GERD Treatment
January 26, 2025
Company
Deals
Sino Biopharmaceutical Secures Rights to Shionogi’s COVID-19 Therapy Ensitrelvir
January 26, 2025
Company
Deals
Shenzhen Core Medical Raises ‘Hundreds of Millions’ in Series C Financing
January 26, 2025
Company
Sinovac Reports H1 2022 Financials Amid COVID-19 Vaccine Demand Decline
January 26, 2025
Company
Drug
Junshi Biosciences’ JT001 (VV116) Shows Non-Inferiority to Paxlovid in COVID-19 Trial
January 26, 2025
Company
Drug
Hainan Shuangcheng Files Paragraph IV Patent Declaration for Paclitaxel, Albumin-Bound
January 26, 2025
Company
Drug
Grand Pharma’s COVID-19 Therapy GS221 Shows Promising Safety Profile
January 26, 2025
Company
Drug
Fosun Pharma Launches Online Registration for BioNTech COVID-19 Vaccine in Hong Kong
January 26, 2025
Company
Drug
Immunotech Biopharm’s CAR-T-19-D2 IND Filing Accepted by NMPA
January 26, 2025
Company
Medical Device
Acotec Scientific Holdings Receives NMPA Approvals for YAN and P-Conic Balloon
January 26, 2025
Company
Drug
CanSino Biologics Updates Data from COVID-19 Vaccine Clinical Studies
January 26, 2025
1
2
3
4
…
22
23
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?